Targeting hypoxia-inducible factors: therapeutic opportunities and challenges

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development

First‐in‐man–proof of concept study with molidustat: a novel selective oral HIF‐prolyl hydroxylase inhibitor for the treatment of renal anaemia